Trial Profile
Study of Human Coagulation Factor IX in patients with Haemophilia B
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Factor IX (Primary)
- Indications Haemophilia B
- Focus Adverse reactions
- 26 Sep 2016 New trial record
- 19 Sep 2016 According to China Biologic Products, Inc media release, company plans to complete this study by 2018.
- 19 Sep 2016 According to China Biologic Products, Inc media release, clinical trial application for FIX was officially accepted by the CFDA in December 2015.